Securities code: Suzhou Huaya Intelligence Technology Co.Ltd(003043) securities abbreviation: Suzhou Huaya Intelligence Technology Co.Ltd(003043) Announcement No.: 2022012 Suzhou Huaya Intelligence Technology Co.Ltd(003043)
Announcement on changing the name, business scope and increasing the registered capital of the company’s subsidiaries
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Suzhou Huaya Intelligence Technology Co.Ltd(003043) (hereinafter referred to as “the company”) held the 12th meeting of the second board of directors on April 18, 2022, deliberated and adopted the proposal on changing the name, business scope and increasing the registered capital of the company’s subsidiaries. Relevant matters are hereby announced as follows:
1、 Relevant matters before this change
Company name: Medicon medical technology (Suzhou) Co., Ltd
Company domicile: No. 58, Chunxing Road, Caohu Industrial Park, Xiangcheng Economic Development Zone, Suzhou
Legal representative: Wang Jingyu
Registered capital: 5000000 yuan
Main business: selling all kinds of precision metal structural parts in the field of medical devices
Total assets: 461568324 yuan
Net assets: 461011823 yuan
Operating income: 0.00 yuan
Operating profit: – 7915746 yuan
Net profit: – 21889415 yuan
(Note: the deadline for the above financial data is December 31, 2021, which is the main financial data of MEDICOM in the latest year).
At present, the company directly holds 100% equity of Medicon medical technology (Suzhou) Co., Ltd.
2、 Proposed changes
The company plans to change the name and business scope of its subsidiary Medicon medical technology (Suzhou) Co., Ltd. and increase its registered capital, as follows:
(1) Name
Before change: Medicon medical technology (Suzhou) Co., Ltd
After change: Suzhou Huachuang Industrial Investment Development Co., Ltd
(2) Business scope
Before change: R & D, production and sales: class I medical devices. (for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments)
After change: general items: equity investment; Engaging in investment activities with its own funds; Asset management services invested by self owned funds; Venture capital (limited to investment in unlisted enterprises); Information consulting services (excluding licensed information consulting services); Enterprise management consulting; business management. (except for the items that must be approved according to law, the company shall independently carry out business activities according to law with its business license)
(3) Registered capital
Before change: RMB 5 million
After change: RMB 100 million
The specific information after the above changes shall be subject to the final industrial and commercial record.
3、 Special note
(1) Medicon medical technology (Suzhou) Co., Ltd. is a wholly-owned subsidiary of the company. This transaction does not constitute a related party transaction or a major asset reorganization stipulated in the administrative measures for major asset reorganization of listed companies. (2) This capital increase is the subscribed registered capital, and the subsequent capital increase will be gradually in place according to the business needs. The subscribed registered capital does not need to occupy funds, but can be withdrawn, which has high operation efficiency and reduces the operation cost of the enterprise.
4、 Documents for future reference
1. Resolution of the 12th meeting of Suzhou Huaya Intelligence Technology Co.Ltd(003043) the second board of directors. It is hereby announced!
Suzhou Huaya Intelligence Technology Co.Ltd(003043) board of directors April 19, 2022
